Market Place
Sourcing Support
iSTAR Medical™s MINIject® shows 5-year efficacy in glaucoma in ST
24 Apr 2025 //
GLOBENEWSWIRE
iSTAR Medical Appoints US Chief Medical Officer And VP
04 Sep 2024 //
GLOBENEWSWIRE
iSTAR Medical Expands International Commercial Rollout of MINIject
10 Jan 2024 //
GLOBENEWSWIRE
iSTAR Medical continues European expansion with first MINIject® surgeries
22 Dec 2023 //
GLOBENEWSWIRE
iSTAR Medical conducts first MINIject® surgeries in Ireland
31 Oct 2023 //
GLOBENEWSWIRE
iSTAR Medical presents positive three-year results for MINIject from trial
07 Sep 2023 //
GLOBENEWSWIRE
iSTAR Medical initiates international STAR-VI trial for the use of MINIject
15 Mar 2023 //
GLOBENEWSWIRE
iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries
01 Dec 2022 //
GLOBENEWSWIRE
iSTAR Medical Presents Positive Results for MINIject Across 3 Glaucoma Trials
08 Jun 2022 //
GLOBENEWSWIRE
iSTAR Medical Presents Positive Consistent Results for MINIject
07 Jun 2022 //
GLOBENEWSWIRE
iSTAR Medical Expands Commercial Rollout with First MINIject Surgeries
10 May 2022 //
GLOBENEWSWIRE
iSTAR Medical Continues Market Expansion with First MINIject Surgeries in the UK
26 Mar 2022 //
GLOBENEWSWIRE
iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject
12 Jan 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.